1. Home
  2. SLS vs SIEB Comparison

SLS vs SIEB Comparison

Compare SLS & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • SIEB
  • Stock Information
  • Founded
  • SLS 2012
  • SIEB 1886
  • Country
  • SLS United States
  • SIEB United States
  • Employees
  • SLS N/A
  • SIEB N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • SIEB Investment Bankers/Brokers/Service
  • Sector
  • SLS Health Care
  • SIEB Finance
  • Exchange
  • SLS Nasdaq
  • SIEB Nasdaq
  • Market Cap
  • SLS 169.6M
  • SIEB 148.8M
  • IPO Year
  • SLS N/A
  • SIEB N/A
  • Fundamental
  • Price
  • SLS $1.54
  • SIEB $4.21
  • Analyst Decision
  • SLS
  • SIEB
  • Analyst Count
  • SLS 0
  • SIEB 0
  • Target Price
  • SLS N/A
  • SIEB N/A
  • AVG Volume (30 Days)
  • SLS 2.6M
  • SIEB 186.1K
  • Earning Date
  • SLS 08-12-2025
  • SIEB 08-13-2025
  • Dividend Yield
  • SLS N/A
  • SIEB N/A
  • EPS Growth
  • SLS N/A
  • SIEB 117.05
  • EPS
  • SLS N/A
  • SIEB 0.46
  • Revenue
  • SLS N/A
  • SIEB $92,064,000.00
  • Revenue This Year
  • SLS N/A
  • SIEB N/A
  • Revenue Next Year
  • SLS N/A
  • SIEB N/A
  • P/E Ratio
  • SLS N/A
  • SIEB $9.23
  • Revenue Growth
  • SLS N/A
  • SIEB 21.82
  • 52 Week Low
  • SLS $0.77
  • SIEB $1.41
  • 52 Week High
  • SLS $2.12
  • SIEB $5.77
  • Technical
  • Relative Strength Index (RSI)
  • SLS 45.96
  • SIEB 39.36
  • Support Level
  • SLS $1.47
  • SIEB $4.34
  • Resistance Level
  • SLS $1.73
  • SIEB $4.71
  • Average True Range (ATR)
  • SLS 0.11
  • SIEB 0.34
  • MACD
  • SLS -0.02
  • SIEB -0.16
  • Stochastic Oscillator
  • SLS 19.44
  • SIEB 4.88

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

Share on Social Networks: